Combined anti-PD-1, HDAC inhibitor and anti-VEGF for MSS/pMMR colorectal cancer: a randomized phase 2 trialFeng Wang, Rui‐Hua Xu, Zhi‐Qiang Wang et al.|Nature Medicine|2024Cited by 162
A novel inflammation-based prognostic score in esophageal squamous cell carcinoma: the C-reactive protein/albumin ratioXiaoli Wei, Rui‐Hua Xu, Feng‐Hua Wang et al.|BMC Cancer|2015Cited by 160
Self-improving generative foundation model for synthetic medical image generation and clinical applicationsJinzhuo Wang, Jia Qu, Kai Wang et al.|Nature Medicine|2024Cited by 115
A phase I study of toripalimab, an anti‐PD‐1 antibody, in patients with refractory malignant solid tumorsXiaoli Wei, Rui‐Hua Xu, Chao Ren et al.|Cancer Communications|2020Cited by 54
Hepatitis B virus infection is associated with younger median age at diagnosis and death in cancersXiaoli Wei, Rui‐Hua Xu, Hui Luo et al.|International Journal of Cancer|2017Cited by 49